Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery

• Peter S. Kutchukian,

  Affiliation Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Nadya Y. Vasilyeva,

  Affiliation Department of Psychology, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Jordan Xu,

  Affiliation Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America

  ⨯
• Mika K. Lindvall,

  Affiliation Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America

  ⨯
• Michael P. Dillon,

  Affiliation Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America

  ⨯
• Meir Glick,

  Affiliation Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• John D. Coley ,

  * E-mail: j.coley@neu.edu (JDC); NBrooijmans@blueprintmedicines.com (NB)

  Affiliation Department of Psychology, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Natasja Brooijmans

  * E-mail: j.coley@neu.edu (JDC); NBrooijmans@blueprintmedicines.com (NB)

  Affiliation Blueprint Medicines, Cambridge, Massachusetts, United States of America

  ⨯